Global Smart Insulin Pen Market, By Product (Smart Insulin Pens, Adaptors for Conventional Pens, Disposable, Reusable), Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Connectivity Type (Bluetooth, USB), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics / Centers) – Industry Trends and Forecast to 2029
Smart Insulin Pen Market Analysis and Size
This smart insulin pen calculates and tracks doses and provides helpful reminders, alerts, and reports. The smart insulin pens also come with extra functions including data transfer, time and dose recorder, and memory function. In the coming years, a crucial aspect that is anticipated to propel the global market for smart insulin pen is the rise in prevalence of the two forms of diabetes in both children and adults, which is caused by obesity and changing lifestyle and dietary habits.
Data Bridge Market Research analyses that the smart insulin pen market which was USD 31.2 million in 2021, would rocket up to USD 62.63 million by 2029, and is expected to undergo a CAGR of 9.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Smart Insulin Pens, Adaptors for Conventional Pens, Disposable, Reusable), Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable) Connectivity Type (Bluetooth, USB), Application (Type 1 Diabetes, Type 2 Diabetes), Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics / Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Emperra GmbH E-Health Technologies (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Pendiq (Germany), Sanofi (France), Berlin-Chemie AG (Germany), Bigfoot Biomedical Inc. (U.S.), Digital Medics Pty Ltd. (Australia), Eli Lilly and Company (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Smart insulin pens are reusable injector pens that can be connected to smartphone apps. The majority of diabetic patients face difficulty to calculate their insulin dosage. The result could be insulin stacking. It helps you to improve insulin administration by managing your diabetes. These "second-generation" pens pair with USB or Bluetooth technology to enable wireless transmission of data to your app.
Global Smart Insulin Pen Market Dynamics
Drivers
- Technological advancements
Emerging technologies in smart insulin pens are projected to drive the global smart insulin pen market during the forecast period. To detect the insulin level, an iSenz adaptor is used for smart insulin pens. It offers injection angles for diabetic injection site optimization. For insulin pens connected to the internet, there is an adaptor called Easylog. In order to manage chronic illnesses such as diabetes, it gives patient the proper dosage and delivers improved comfort. InsulCheck is a cap that fits insulin pens and has a sensor to monitor temperature and consumption. And these are some of the examples of smart insulin pens which accelerate the market growth.
- Integration of monitoring and therapeutic features
Smart insulin pens have many benefits for diabetes management. These pens have extra features that make it easier to keep track of the previous insulin dose. Daily injections of insulin with a syringe and needle are challenging and unpleasant. With improvements in device communication technology, more people are using their smartphones and the internet to track their records and drives the market's growth.
Opportunities
Integrated technology measuring blood glucose levels and determining insulin dosage. Patients can provide their information to doctors or other healthcare experts through sophisticated technological tools and apps. For instance, In pen insulin pens are linked to smartwatches, armbands, and smart apps, which assist in tracking physical activity and transmitting the information to doctors. The US market has seen increased competition from a number of manufacturers. For instance, Novo Nordisk's NovoPen® 6 and NovoPen Echo® Plus, which can record and save the past 800 injection doses, including airshots, and enable optimal insulin management, were approved for use in 2019.
Restraints/Challenges
- Increased adoption of refurbished systems
On the other hand, the high cost of insulin pens, poor reimbursement rates will obstruct the market's growth rate. It's common for refurbished systems to cost less than brand-new ones. For industry participants, particularly small manufacturers, the rising demand for refurbished products poses a significant challenge.
This smart insulin pen market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smart insulin pen market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In February 2020, A partnership between Senseonics and Companion Medical was announced. Senseonics is a US-based medical technology firm that primarily focuses on designing, developing, and marketing glucose monitoring systems. The relationship will benefit both businesses by fusing the Eversense CGM Technology with the InPenT smart system for precise insulin delivery.
- In March 2022, Novo Nordisk announced the Novo Pen 6 and Novo Pen Echo Plus, two smart linked insulin pens that are currently available in the UK on prescription for those with diabetes who use Novo Nordisk insulin. These two new smart insulin pens, the Novo Pen 6 and Novo Pen Echo Plus, record each injection's insulin dosage automatically.
Global Smart Insulin Pen Market Scope
The smart insulin pen market is segmented on the basis of usability, product type, connectivity type, application and distribution-channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Usability
- Prefilled
- Reusable
Product
- Smart Insulin Pens
- Adaptors for Conventional Pens
- Disposable
- Reusable
Connectivity Type
- Bluetooth
- USB
Application
- Type 1 Diabetes
- Type 2 Diabetes
Distribution Channel
- Hospital Pharmacies
- Online Sales
- Retail Pharmacies
- Diabetes Clinics / Centers
Smart Insulin Pen Market Regional Analysis/Insights
The smart insulin pen market is analysed and market size insights and trends are provided by country, product type, connectivity type, application and distribution-channel as referenced above.
The countries covered in the smart insulin pen market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the smart insulin pen market due to rise in prevalence of diabetes, new product launches and high cost of smart insulin pen are also expected to contribute to the regional market growth.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increase in geriatric population with diabetes in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The smart insulin pen market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart insulin pen market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart insulin pen market. The data is available for historic period 2010-2020.
Competitive Landscape and Smart Insulin Pen Market Share Analysis
The smart insulin pen market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to smart insulin pen market.
Some of the major players operating in the smart insulin pen market are:
- Emperra GmbH E-Health Technologies (Germany)
- Medtronic (Ireland)
- Novo Nordisk A/S (Denmark)
- Pendiq (Germany)
- Sanofi (France)
- Berlin-Chemie AG (Germany)
- Bigfoot Biomedical Inc. (U.S.)
- Digital Medics Pty Ltd. (Australia)
- Eli Lilly and Company (U.S.)
SKU-